{"organizations": [], "uuid": "f85f71de6073f4e507244e82ac980887901aace9", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180410.html", "section_title": "Archive News &amp; Video for Tuesday, 10 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-broadfin-capital-reports-73-pct-st/brief-broadfin-capital-reports-7-3-pct-stake-in-biodelivery-sciences-idUSFWN1RN07D", "country": "US", "domain_rank": 408, "title": "BRIEF-Broadfin Capital Reports 7.3 Pct Stake In Biodelivery Sciences", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.005, "site_type": "news", "published": "2018-04-10T18:52:00.000+03:00", "replies_count": 0, "uuid": "f85f71de6073f4e507244e82ac980887901aace9"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-broadfin-capital-reports-73-pct-st/brief-broadfin-capital-reports-7-3-pct-stake-in-biodelivery-sciences-idUSFWN1RN07D", "ord_in_thread": 0, "title": "BRIEF-Broadfin Capital Reports 7.3 Pct Stake In Biodelivery Sciences", "locations": [], "entities": {"persons": [], "locations": [{"name": "biodelivery", "sentiment": "none"}, {"name": "biodelivery", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "biodelivery sciences international inc", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 10 (Reuters) - BioDelivery Sciences International Inc :\n* BROADFIN CAPITAL LLC REPORTS 7.3 PCT STAKE IN BIODELIVERY SCIENCES INTERNATIONAL INC AS OF APRIL 5 - SEC FILING\n* PURCHASED BIODELIVERY SCIENCES INTERNATIONAL SHARES BASED ON BELIEF THAT SHARES, WHEN PURCHASED, “WERE UNDERVALUED”\n* INTEND TO ENGAGE IN DISCUSSIONS WITH BIODELIVERY SCIENCES INTERNATIONAL REGARDING BOARD STRUCTURE AND COMPOSITION\n* WAS INFORMED BIODELIVERY SCIENCES NOMINATING COMMITTEE DECIDED NOT TO PROCEED WITH APPOINTMENT OF STOCKHOLDER REPRESENTATIVE\n* IF MUTUALLY AGREEABLE RESOLUTION WITH BIODELIVERY SCIENCES INTERNATIONAL NOT REACHED, RESERVE RIGHTS TO NOMINATE DIRECTOR CANDIDATES Source text: ( bit.ly/2qpEtoH ) Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "https://bit.ly/2qpEtoH", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-10T18:52:00.000+03:00", "crawled": "2018-04-11T17:52:48.006+03:00", "highlightTitle": ""}